Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
New York State Psychiatric Institute
ClinicalTrials.gov Identifier:
NCT00369746
First received: August 24, 2006
Last updated: April 9, 2014
Last verified: December 2011
Results First Received: November 23, 2011  
Study Type: Observational
Study Design: Observational Model: Case Control;   Time Perspective: Prospective
Conditions: Major Depressive Disorder
Alcohol Use Disorder
Intervention: Drug: citalopram

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
Participants were recruited from all participants entering the Sequenced Treatment Alternatives to Relieve Depression clinical trial.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Alcohol Abuse or Dependence Subjects with alcohol abuse or dependence and Major Depression
Major Depression Only Major Depression without alcohol abuse disorder

Participant Flow:   Overall Study
    Alcohol Abuse or Dependence     Major Depression Only  
STARTED     138     536  
COMPLETED     138     536  
NOT COMPLETED     0     0  



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Alcohol Abuse or Dependence Subjects with alcohol abuse or dependence
Major Depression Only Major Depression without alcohol abuse disorder
Total Total of all reporting groups

Baseline Measures
    Alcohol Abuse or Dependence     Major Depression Only     Total  
Number of Participants  
[units: participants]
  138     536     674  
Age  
[units: participants]
     
<=18 years     0     0     0  
Between 18 and 65 years     138     536     674  
>=65 years     0     0     0  
Age  
[units: years]
Mean ± Standard Deviation
  36.7  ± 12.3     39.5  ± 13.4     38.9  ± 13.2  
Gender  
[units: participants]
     
Female     77     134     211  
Male     61     402     463  
Region of Enrollment  
[units: participants]
     
United States     138     536     674  



  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Quick Inventory of Depression- Self Report 16   [ Time Frame: study exit visit, at Week 12 ]

2.  Secondary:   Timeline Follow Back (TLFB) Average Drinks Per Drinking Day   [ Time Frame: 30 days ]

3.  Secondary:   Quantitative Substance Use Inventory ((SUI)   [ Time Frame: 30 days ]

4.  Secondary:   Timeline Follow Back (TLFB) Drinking Days Per 30 Days   [ Time Frame: 30 days ]

5.  Secondary:   Timeline Follow Back (TLFB) Maximum Drinks Per Drinking Day   [ Time Frame: 30 days ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Patrick J. McGrath, M.D.
Organization: New York State Psychiatric Institute
phone: 646-774-8076
e-mail: mcgrath@nyspi.columbia.edu


No publications provided


Responsible Party: New York State Psychiatric Institute
ClinicalTrials.gov Identifier: NCT00369746     History of Changes
Other Study ID Numbers: #5173, R01AA013303
Study First Received: August 24, 2006
Results First Received: November 23, 2011
Last Updated: April 9, 2014
Health Authority: United States: Institutional Review Board